Association for Clinical Oncology: Proposed Changes to Federal Health Agencies Threaten Future Cancer Research Advancements

1. ASCO assesses the Administration’s proposed budget for FY 2026, expressing concerns about the impact on federal health agencies and medical research. 2. Dr. Eric P. Winer highlights the potential negative effects on cancer care and research due to the proposed cuts to NIH and CDC. 3. The proposed 40% cut to NIH funding could hinder scientific breakthroughs and vital research. 4. ASCO emphasizes the vital role of federally funded research and prevention efforts in cancer care and patient outcomes. 5. Dr. Winer urges lawmakers to prioritize federal research funding to maintain the U.S.'s research reputation and results.